Lenalidomide Market Outlook Lenalidomide is an immunomodulatory drug that is vital to the treatment of cancers including multiple myeloma and myelodysplastic syndromes. When taken orally, its precise mode of action is still mostly unclear, however it involves immune system alteration and anti-tumor properties. It is commonly used in combination therapy because it inhibits angiogenesis, which...

“Global Lenalidomide Market size and share is currently valued at USD 10.86 billion in 2024 and is anticipated to generate an estimated revenue of USD 15.67 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 4.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032” Polaris...